This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (60)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Clinical Trial

Jeremiah G. Turcotte, MD; Nicholas J. Feduska, MD; Richard F. Haines, PhD; Duane T. Freier, MD; Paul W. Gikas, MD; Franklin D. McDonald, MD; Arthur G. Johnson, PhD; Roger M. Morrell, MD, PhD; Norman W. Thompson, MD

AMA Arch Surg. 1973;106(4):484-488.

Abstract
Thirty-six intrafamilial and 35 cadaveric transplants performed consecutively between June 1969 and March 1971 were prospectively randomized into a control group and one treated with horse antihuman thymocyte globulin (HATG). All histocompatible related allografts are functioning regardless of whether HATG was used. Two year life-table survival for incompatible related grafts is 85.7% for HATG treated vs 58.4% for concurrent control grafts, while there was no difference in transplant survival of cadaveric grafts whether or not HATG was administered. Significantly fewer rejection episodes occurred in HATG cadaveric grafts. No differences in renal function, renal histologic findings, infections and other complications, or steroid requirements were noted when HATG-treated recipients were compared with control patients.

Author Affiliations
Ann Arbor, Mich

From the Section of General Surgery (Drs. Turcotte, Feduska, Haines, Freier, and Thompson) and departments of medicine (Dr. Mc Donald), microbiology (Dr. Johnson), and pathology (Dr. Gikas), University of Michigan Medical Center, Ann Arbor; and the Research Laboratories, the Upjohn Co., Kalamazoo, Mich (Dr. Morrell).

Footnotes
Accepted for publication Jan 4, 1973.

Read before the 80th annual meeting of the Western Surgical Association, Rochester, Minn, Nov 17, 1972.

Reprint requests to University of Michigan Medical Center, Section of General Surgery, 1405 E Ann St, Ann Arbor, Mich 48104 (Dr. Turcotte).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Factors Affecting the Frequency of Infection in Renal Transplant Recipients
Murphy et al.
Arch Intern Med 1976;136:670-677.
ABSTRACT  

Antithymocyte Globulin in Renal Transplant Recipients: Report of a Prospective Randomized Controlled Trial
Chatterjee
Arch Surg 1976;111:680-683.
ABSTRACT  

Pneumonia in Recipients of Renal Allografts
Huertas et al.
Arch Surg 1976;111:162-166.
ABSTRACT